Yüklüyor......
EGFR-TKI, Erlotinib, Causes Hypomagnesemia, Oxidative Stress and Cardiac Dysfunction: Attenuation by NK-1 Receptor Blockade
To determine whether the EGFR tyrosine kinase inhibitor, erlotinib may cause hypomagnesemia, inflammation and cardiac stress, erlotinib was administered to rats (10 mg/kg/day) for 9 weeks. Plasma magnesium decreased progressively between 3-9 weeks (-9 to -26%). Modest increases in plasma substance P...
Kaydedildi:
| Yayımlandı: | J Cardiovasc Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4286425/ https://ncbi.nlm.nih.gov/pubmed/25343568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000163 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|